The CCK-A receptor gene possibly associated with auditory hallucinations in schizophrenia
- 16 April 1999
- journal article
- Published by Cambridge University Press (CUP) in European Psychiatry
- Vol. 14 (2) , 67-70
- https://doi.org/10.1016/s0924-9338(99)80719-6
Abstract
Summary: In this study, a PstI polymorphic site with two individual alleles, namely A1 and A2, was identified within the boundary between intron 1 and exon 2 of the cholecystokinin (CCK) type A receptor gene. The PstI polymorphic site was used as a genetic marker to study its association with psychotic symptoms in schizophrenia. A significant difference in allelic frequency was found between schizophrenic patients with and without auditory hallucinations (χ2 = 6.26, df = 1, P = 0.012), and the odds ratio for the allelic association was 2.21 (95% CI 1.18–4.15) with an attributable fraction of 0.1. The frequency of A1-A1 and A1-A2 genotypes showed a significant excess in schizophrenic patients with auditory hallucinations as compared to those without such symptoms (χ2 = 5.45, df = 1, P = 0.02), and the odds ratio for the genotypic association was 2.27 (95% CI 1.13–4.57) with an attributable fraction of 0.177. The haplotype-based haplotype relative risk (HHRR) test revealed a significant difference between transmitted and non-transmitted alleles in nuclear families of schizophrenic patients with auditory hallucinations (χ2 = 4.54, df = 1,P = 0.033) but not in those of schizophrenic patients without them. The present study suggests that the CCK-A receptor gene may be associated with auditory hallucinations in schizophrenia.Keywords
This publication has 23 references indexed in Scilit:
- Platelet monoamine oxidase activity in relation to alleles of dopamine D4 receptor and tyrosine hydroxylase genesActa Psychiatrica Scandinavica, 1997
- Association between schizophrenia and a microsatellite polymorphism at the dopamine D5 receptor genePsychiatric Genetics, 1997
- The case for heterogeneity in the etiology of schizophreniaSchizophrenia Research, 1995
- Cholecystokinin messenger RNA deficit in frontal and temporal cerebral cortex in schizophreniaBiological Psychiatry, 1995
- Delusions and Hallucinations in Schizophrenic PatientsPsychopathology, 1993
- Cholecystokinin-dopamine intearctionsTrends in Pharmacological Sciences, 1991
- A mechanism for the involvement of colocalized neuropeptides in the actions of antipsychotic drugsBiological Psychiatry, 1989
- A double-blind study with ceruletide in chronic schizophrenic patients: Biochemical and clinical resultsPsychiatry Research, 1986
- Cholecystokinin and SchizophreniaPublished by Elsevier ,1986
- Cholecystokinin peptides, dopamine and schizophrenia — A reviewProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1985